Login

Vection Technologies Ltd's software adapts existing CAD programs for real-time collaboration and visualization. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jonah Goldberg: The Constraints of Conservatism
00:10:00
Lauren Han of KKR on Capital Markets and IPO Preparation
00:10:00
Q&A: Dalrymple Bay Infrastructure (ASX:DBI) CEO Anthony Timbrell on Half-Year Results | Michael Riches - Chief Executive Officer of Dalrymple Bay Infrastructure
00:00:00
1:03 / 7:30 • Key Successes Futura Medical marks pivotal year with first meaningful revenue from Eroxon sales - James Barder, CEO, Futura Medical
00:10:00
Client Testimonial: Trust and Success with Personalized Financial Guidance
00:10:00
Mineros Resources: Unlocking Growth as an Emerging Mid-Tier Gold Producer in Colombia and Nicaragua
00:10:00
Medtech Meltdown: Can Healthcare Innovation Weather a VC Storm|Amy Cheetham,Partner,Costanoa Ventures
00:10:00
ALIGNED WITH MANAGEMENT TO BUILD VALUE|Jeff Dombek,Vice President,The Jordan Company, L.P.
00:10:00
Henderson Land Honored in Singapore with Second 'Developer of the Year' Award|Mr Yu Ching Yan Johnny,Advisor to Chairman,Henderson Land Development Co. Ltd.
00:10:00
Bit Digital CEO on Q2 Earnings, Headwinds in the Mining Industry | Bryan Bullett, CEO, Bit Digital IncBTBT:NAQ
00:10:00
Enjoying 25 Years on the Nasdaq Exchange, Ballard | Mark Biznek, COO, Ballard Power Systems IncBZAF:FRA
00:10:00
Stephen Lang Discusses Centerra's 2012 Production Outlook and Central Asia Focus

© 2017 - Neuhu+